NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Indices Maintain Upward Momentum for Second Consecutive Week

The broader indices in the Indian stock market continued their upward momentum for the second consecutive week, outperforming the benchmark indices. This surge was driven by strong buying in auto, healthcare, defence, and realty stocks.

During the week, the BSE Sensex advanced 414.69 points, or 0.53%, to close at 77,328.19, while the Nifty 50 gained 178.6 points, or 0.74%, to settle at 24,176.15. The broader markets outperformed the benchmark indices, with the Nifty Midcap 100 and Nifty Smallcap indices rising 3.5% and 4%, respectively.

IndexGain (%)Previous High
Nifty Midcap 1003.5%62,113.85
Nifty Smallcap4%19,224.95

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The Nifty Midcap 100 index touched a fresh record high of 62,113.85 during the week, while the Nifty Smallcap index moved closer to the 18,800 mark, trading just 2.2% below its all-time high of 19,224.95.

The rally in the midcap index was led by strong gains in stocks such as Yes Bank, Bharat Heavy Electricals (BHEL), Coforge, Polycab India, Laurus Labs, Dabur India, SRF, and Motilal Oswal Financial Services.

Domestic Institutional Investors (DIIs) continued their buying momentum, purchasing equities worth ₹21,392.85 crore, during the week. However, Foreign Institutional Investors (FIIs) remained net sellers, offloading equities worth ₹11,072.35 crore.

The total market capitalisation of BSE-listed companies rose more than ₹10 lakh crore during the week.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Technical analysts Rajesh Bhosale and Rupak De provided insights into the market's future trajectory. Bhosale noted that the Nifty has now gained for the second consecutive week, but technically not much has changed, as prices over the past two weeks have continued to gyrate within a narrow range. He added that the 24,500–24,600 zone remains a stiff hurdle, restricting a momentum breakout.

De stated that the index has slipped back below the 50 EMA after briefly staying above it, indicating renewed weakness in sentiment. He also noted that the mood has further deteriorated as the index also moved below the 50 EMA on the intraday timeframe.

Sectoral indices ended the week in the green, led by the Nifty Capital Markets index, which surged 5.7%. The Nifty Auto index gained 5%, while the Nifty Defence index advanced 4.6%. Meanwhile, the Nifty Realty, Pharma, and Healthcare indices each climbed around 3.5%. On the downside, the Nifty PSU Bank index declined 1.3%, while the Nifty Oil & Gas index slipped 0.8% during the week.

Momentum indicators and oscillators are showing signs of improvement, with the RSI hovering around 46. The broader structure continues to remain sideways to positive, and a gradual recovery towards 24,300–24,500 levels is likely in the near term, while the crucial support of the 50-DMA is placed around 24,000 levels.

Investor Takeaway

Investors should consider allocating to midcap stocks, which have shown strong gains in recent weeks.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.